Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Dividend Distribution
confidence 95%
filed 2026-07-01
The 6-K discloses that Grupo Aval made a dividend payment in July 2026 pursuant to a profit distribution approved by shareholders on March 27, 2026. The notice explicitly states "the payment of dividends scheduled for July 2026, was made in accordance with the Proposed Distribution of Profits." This is a dividend distribution event material to investors as it affects capital returns and cash flow.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-07-01
Item 2.03
Avis Budget Group entered into the Eleventh Amendment to its credit agreement on June 29, 2026, refinancing an existing $2 billion revolving facility with a new $2 billion revolving facility maturing in 2031 and establishing a new $200 million revolving facility maturing in 2028.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-01
EX-99.4
British American Tobacco disclosed H1 2026 financial results and full-year 2026 guidance, including detailed performance metrics across business segments (U.S., AME, APMEA) and product categories, with mid-teens revenue growth expectations for H1 and full-year 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Bruce Hausmann as a director of Mativ Holdings, effective July 1, 2026, to fill a newly created board vacancy. The Board increased from 6 to 7 members and appointed Hausmann as a Class I director with a term expiring at the 2029 Annual Meeting. He was also appointed to the Audit Committee and qualifies as an "audit committee financial expert." This is a clear executive appointment event, material to investors as it affects board composition and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-01
Item 2.02
MSC Industrial Direct issued a press release on July 1, 2026 announcing financial results for fiscal 2026 third quarter ended May 30, 2026. The disclosure includes detailed financial highlights (net sales of $1,047.1M up 7.8% YoY, diluted EPS of $1.44 vs. $1.02 prior year), condensed consolidated financial statements, and forward guidance for Q4 and full-year fiscal 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The disclosure centers on the appointment of Alison L. Hannah, M.D. as Executive Vice President and Chief Medical Officer of Rigel Pharmaceuticals, effective July 1, 2026. While the filing also mentions Dr. Hannah's concurrent resignation from the Board and the departure of the prior CMO, Lisa Rojkjaer, the principal action disclosed is the appointment of a named executive officer to a C-suite position. This is material to investors as it affects the Company's senior leadership and medical strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-01
EX-99.1
GreenPower announced completion of the third tranche of Series A Convertible Preferred Shares in a private placement for US$1,425,000 gross proceeds, with the shares convertible into common shares at a specified conversion rate. The Company also amended the underlying Securities Purchase Agreement to increase the aggregate stated value by US$2 million. This is a dilutive equity issuance that raises capital through convertible securities, a material event affecting shareholder equity and ownership structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-01
Item 8.01
BFNH received an assignment of approximately 19,957 acres of federal oil and gas leases in Nevada from its majority shareholder (pending BLM approval), representing a strategic pivot from vitamin supplement operations to oil and gas exploration and production. This is a material operational and strategic business event—a significant asset acquisition and business transformation—that does not fit the specific M&A categories (which typically address acquisitions of companies or control changes) but clearly affects the registrant's business direction and investor assessment. The company has engaged Ryder Scott to evaluate development potential, signaling serious intent to pursue this new business line.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 85%
filed 2026-07-01
EX-99.1
The exhibit discloses a Board-approved grant of 2,475,000 stock options to the CEO at $4.32 per share with a ten-year term and four-year vesting schedule subject to performance milestones. This is a material compensatory arrangement for a named executive officer (CEO Francis Bellido) that would affect investor assessment of executive compensation and capital structure. While the exhibit also announces sponsorship of an industry summit, the substantive disclosure triggering SEC/regulatory reporting is the equity grant.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-01
EX-99.4
TotalEnergies deployed MethaneLive, a real-time methane emissions monitoring center leveraging 13,000 sensors and AI to detect and reduce methane emissions across operated sites, advancing the company's 2030 near-zero methane emissions commitment.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-01
EX-99.6
TotalEnergies signed entry into the Bab Gas Cap Concession in Abu Dhabi with a 10% interest alongside ADNOC and other partners, targeting 1.5 billion cubic feet per day production as a significant growth opportunity in the company's upstream strategy.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-07-01
EX-99.7
TotalEnergies issued 5,548,563 new shares on June 26, 2026, through a capital increase reserved for employees at €62.00 per share, raising €310.5 million and increasing employee shareholders' stake to 7.6% of share capital.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-01
Item 8.01
Kroger announced entry into an agreement and plan of merger to acquire Giant Eagle, Inc. for approximately $1.65 billion in cash and assumed liabilities. This is a material acquisition disclosed under Item 8.01 (Other Events), representing a significant M&A transaction that would materially affect investor assessment of the registrant's capital deployment and strategic direction.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
The filing discloses the appointment of Nnamdi Njoku as President of Omnicell, effective July 1, 2026, while retaining his COO role. Although the disclosure also mentions that Randall Lipps stepped down from the President role, the principal action disclosed is Njoku's appointment and promotion to President. The filing emphasizes his expanded responsibilities in shaping long-term growth strategy and operational execution, and includes a material equity award of approximately $500,000 in restricted stock units as part of the promotion.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-01
Item 2.02
CION Investment Corporation announced the scheduling of its second quarter 2026 earnings release and conference call for August 6, 2026 at 11:00 a.m. ET, providing investors with notice of when financial results for the quarter ended June 30, 2026 will be disclosed.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-07-01
Item 1.01
Battalion Oil entered into a Third Amended and Restated Senior Secured Credit Agreement on June 30, 2026, refinancing its existing credit facility with a $162.5 million term loan and up to $175 million in discretionary delayed draw capacity. The refinancing reduces borrowing costs by 125+ basis points, extends maturity to December 31, 2029, and defers principal amortization for one year, materially modifying the company's debt structure and financial obligations.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-01
Item 7.01
Transocean announced entry into a material contract with Equinor valued at over $1 billion in contract backlog for the use of three harsh environment semisubmersible rigs on the Norwegian shelf over seven rig years, with day rates of $399,000–$400,000+.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 8.01
Transocean's proposed business combination with Valaris Limited, announced February 9, 2026, achieved a key regulatory milestone with CFIUS approval on June 29, 2026; HSR Act review is ongoing with a Second Request issued by the DOJ on May 4, 2026, and completion is expected in H2 2026.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-07-01
EX-99.1
The exhibit announces completion of USD 640 million in debt-to-equity conversions by Geely Sweden Holdings AB and Volvo Cars, plus extension of a subordinated term loan facility to 30 June 2027 and an increase of the Green Trade Finance Facility to EUR 450 million. While these are primarily conversions of existing debt rather than new debt issuance, they represent material modifications to Polestar's capital structure and direct financial obligations. The debt maturity profile extension and facility increases are material financial events affecting the registrant's obligations and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-01
Item 2.01
Select Medical Holdings Corporation was acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe for $16.50 per share (approximately $3.9 billion enterprise value) pursuant to a Merger Agreement dated March 2, 2026. The merger became effective on July 1, 2026, resulting in a change of control, conversion of all outstanding shares to cash consideration, and delisting from NYSE.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-01
Item 7.01
The filing discloses the declaration of a quarterly dividend of $0.190 per share payable on July 17, 2026, to common stockholders of record on July 13, 2026. This is a routine but material dividend distribution announcement for a REIT, which typically distributes substantial portions of taxable income to shareholders on a quarterly basis. The disclosure clearly identifies the per-share amount, payment date, and record date.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-01
Item 2.01
Richmond Mutual Bancorporation completed its merger with The Farmers Bancorp effective July 1, 2026, with Richmond as the surviving corporation. Farmers shareholders received 3.40 shares of Richmond common stock per Farmers share, resulting in the issuance of approximately 6.25 million shares.
View raw filing on EDGAR →
6-K
Earnings release
confidence 75%
filed 2026-07-01
EX-99.1
This exhibit is a press release announcing Biophytis's provisional, unaudited financial results for fiscal year 2025, including net loss of €7.8 million, cash position of €190 thousand, and a going-concern disclosure. While the results are presented as "provisional" pending audit completion, the disclosure of annual financial results, material uncertainty regarding going concern, and strategic updates constitute a material earnings announcement that would affect a reasonable investor's assessment of the company's financial condition and viability.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-07-01
Item 5.07
The filing discloses the outcome of the Company's annual meeting of stockholders held on July 1, 2026. Although the specific vote results are not detailed, the material fact disclosed is that the meeting failed to achieve quorum and was adjourned to July 30, 2026. This is a shareholder vote matter under Item 5.07, and the failure to achieve quorum at an annual meeting is material to investors as it affects governance proceedings and the timing of shareholder actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-01
Item 5.07
This Item 5.07 disclosure presents the complete results of Hyperion DeFi's 2026 Annual Meeting of Stockholders held on June 30, 2026, including voting outcomes on five proposals: election of five directors, ratification of auditors (CBIZ CPAs P.C.), advisory approval of named executive officer compensation, approval of an amended certificate of incorporation (which failed), and approval of meeting adjournment authority. The filing explicitly states "The results of the proposals at the Annual Meeting are set forth below," making this a textbook shareholder vote results disclosure material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-01
Item 8.01
Arbor Realty Trust priced a $325 million offering of 6.25% Convertible Senior Notes due 2029 in a private placement to qualified institutional buyers on June 30, 2026. This is a material creation of a new direct financial obligation. While the filing also discloses concurrent share repurchases and a prepaid forward transaction, the primary disclosed event is the debt issuance itself, which is the core capital-raising activity and creates the principal new obligation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-01
Item 2.01
QXO completed its acquisition of TopBuild Corp. on July 1, 2026, for approximately $6.4 billion in cash and 312.5 million QXO shares, making TopBuild a wholly owned subsidiary. The transaction significantly expands QXO's scale and capabilities across the building products value chain, with expected annual synergies of at least $300 million by 2030 and anticipated accretion to earnings.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
QXO appointed Alec Covington as a director effective upon completion of the TopBuild Merger and appointed Madeline Otero as Interim Chief Accounting Officer effective July 1, 2026, with specified compensation including $400k base salary, $600k equity target, and $500k retention award.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
Item 1.01
NN Inc. entered into a Securities Purchase Agreement on June 30, 2026, to sell 24,509,804 shares of common stock in a private placement at $3.06 per share, generating $75.0 million in gross proceeds. The unregistered private placement under Section 4(a)(2) of the Securities Act and Regulation D is material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-07-01
Item 2.01
Cumberland Pharmaceuticals completed the sale of its branded pharmaceutical business to Apotex and affiliates for $100 million in cash on July 1, 2026, following shareholder approval on June 24, 2026 with 99% support. The transaction fundamentally restructures the company to focus on its rare disease pipeline, eliminating substantially all revenue-generating operations. Amendment No. 1 to the acquisition agreement excluded certain contracts from the transferred assets, and the related credit facility was terminated upon closing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-01
Item 5.02
The disclosure centers on John Vong's appointment as Senior Vice President – Accounting and his succession to the principal accounting officer role effective August 7, 2026, following Glenn Sobotka's retirement. While both a departure and appointment occur, the filing emphasizes Vong's appointment and qualifications, making the appointment the principal disclosed action. The change in the principal accounting officer is material to investors assessing the company's financial reporting oversight.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-07-01
Item 2.01
QXO completed its acquisition of TopBuild on July 1, 2026, pursuant to a two-step merger structure (Titanium Merger and Forward Merger), with merger consideration of $505.00 cash or 20.200 QXO shares per TopBuild share, and 91% of shareholders electing cash. The transaction includes $6.0 billion+ in new financing arrangements (term loans, secured notes, and ABL facility) and results in TopBuild becoming a QXO subsidiary.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-01
Item 2.03
In connection with the TopBuild acquisition, QXO entered into material definitive agreements creating $6.0 billion+ in new direct financial obligations, including a $3.0 billion incremental term loan, $3.0 billion in secured notes, and a $2.0 billion ABL facility, while simultaneously terminating TopBuild's prior credit agreement and purchasing/redeeming substantially all of TopBuild's outstanding senior notes (2029, 2032, and 2034 maturities).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-01
Item 3.01
TopBuild's common stock (ticker BLD) was delisted from NYSE effective July 1, 2026, following completion of the merger with QXO; NYSE filed Form 25 to initiate deregistration under Section 12(b) of the Exchange Act, and TopBuild intends to file Form 15 to deregister under Section 12(g) and suspend reporting obligations.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-07-01
Item 5.02
Joseph M. Viselli, a named executive officer of TopBuild, voluntarily resigned from his employment on June 30, 2026, following his retirement, and received severance compensation of $894,539 in cash.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-01
EX-99.1
The exhibit announces completion of a strategic acquisition of 16 NVIDIA Blackwell B300 AI servers for US$1.0 million in cash and US$10.0 million in equity, closed June 28, 2026. The press release explicitly states this transaction "materially strengthens our balance sheet" and represents "an important milestone in both its strategic expansion into AI computing infrastructure." The acquisition is material to the registrant's financial position and strategic direction, satisfying the M&A activity classification under Item 1.01 / 2.01 equivalent disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-07-01
Item 1.01
Jackson Financial entered into a $1.25 billion Revolving Credit Agreement on June 30, 2026, with Wells Fargo as Administrative Agent, replacing its prior $1 billion facility. The agreement includes customary financial maintenance covenants and extends the company's borrowing capacity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-01
Item 5.02
Uwe Breitweg, Vice President Powertrain, Emission and Battery Strategy of the BMW Group, was appointed as a Class III director of Solid Power effective July 1, 2026, pursuant to BMW Holding's director nomination rights. The appointment is material given Breitweg's two decades of automotive leadership, deep battery strategy expertise, and BMW's role as a key development partner.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 8.01
The disclosure describes Sysco's filing of a Form S-4 registration statement in connection with a merger agreement dated March 30, 2026, involving multiple merger subsidiaries and the acquisition of JRD Unico, Inc. and Warehouse Realty, LLC. The Form S-4 contemplates issuance of New Slider HoldCo common stock to Sysco shareholders, indicating a material acquisition or change-of-control transaction requiring SEC registration and shareholder approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 2.01
S&P Global completed the separation of its Mobility division into an independent, publicly-traded company, Mobility Global Inc., through a pro-rata distribution of 100% of Mobility Global shares to S&P Global stockholders effective July 1, 2026. The separation was effected through multiple definitive agreements (Separation and Distribution Agreement, Tax Matters Agreement, Transition Services Agreement, Employee Matters Agreement) and resulted in Mobility Global obtaining its own NYSE listing (MBGL) while S&P Global retained no ownership interest.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 2.01
Mobility Global Inc. completed its separation from S&P Global Inc. on July 1, 2026, becoming an independent, publicly-traded company. S&P Global distributed 100% of Mobility Global's outstanding common stock to S&P Global shareholders on a 1:1 basis, with Mobility Global commencing trading on the NYSE under ticker MBGL. The separation was governed by multiple definitive agreements including a Separation and Distribution Agreement, Tax Matters Agreement, Transition Services Agreement, and Employee Matters Agreement.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-07-01
Item 5.02
Effective July 1, 2026, Mobility Global appointed a substantially reconstituted board of seven new directors (Eric W. Aboaf, William W. Eager, Heather Lavallee, Monique F. Leroux, Mark S. Peek, Shilpa Ranganathan, and Alexander Taussig), appointed Joseph R. Hinrichs as Chair, and appointed three new officers: Scott Fredericks as President of CARFAX, Joseph S. LaFeir as President of Mobility Business Solutions, and Renato Negro as Chief Accounting Officer. These appointments reflect the company's transition to independent public company status following its separation from S&P Global.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-07-01
Item 1.01
Ares Acquisition Corp III consummated an IPO on July 1, 2026, raising $395 million in gross proceeds and entering into multiple material definitive agreements including underwriting, warrant, trust, and registration rights agreements. The SPAC structure is oriented toward a future business combination.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
Item 3.02
The Sponsor purchased 7,466,667 warrants at $1.50 per warrant for $11.2 million in proceeds concurrent with the IPO, representing a material private placement of unregistered equity securities.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-01
Item 5.03
The disclosure reports stockholder approval and Board implementation of a 1-for-20 reverse stock split, effected through amendments to the Company's Restated Certificate of Incorporation. While a reverse stock split is a governance/capital structure matter rather than a named event type, it is material to investors as it affects share count, ownership percentages, and stock price mechanics. The event is clearly governance-related but does not fit the specific categories of exec_appointment, exec_departure, exec_compensation, or shareholder_vote_results (which typically refers to voting on directors or compensation plans rather than capital structure amendments).
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-01
EX-99.1
IperionX announced receipt of up to US$6.6 million in government funding from the U.S. Department of War's Office of the Secretary of War – Submarine Workforce and Industrial Base program (OSW-SWIB) to scale titanium manufacturing capacity for defense applications, plus a separate purchase order for JLTV fasteners. This is a material operational and strategic milestone—a significant government contract award supporting the company's core business strategy to establish domestic titanium manufacturing for defense customers. While not a discrete M&A transaction, earnings release, or financial obligation, it represents a material operational development that would affect a reasonable investor's assessment of the company's growth prospects and strategic positioning.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-07-01
The Company announced on June 30, 2026 a planned offering of corporate bonds in Greece with a maximum aggregate nominal amount of €100 million, consisting of up to 100,000 bonds with a five-year term to be admitted to trading on Euronext Athens. This constitutes creation of a new direct financial obligation and falls squarely within debt_issuance. The materiality is clear given the €100 million size and the explicit disclosure in a 6-K filing.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 7.01
Getty Images' Board unanimously resolved to terminate the Merger Agreement with Shutterstock following the passage of the Second Extended End Date on July 6, 2026, after regulatory conditions imposed by the U.K. CMA required a sale of Shutterstock's editorial business, which Getty Images declined to pursue.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-01
Item 1.01
Vishay entered into an underwriting agreement on June 29, 2026 to offer and sell 15,000,000 shares of common stock at $50 per share, with underwriters exercising a 30-day option for an additional 2,250,000 shares on June 30, 2026, generating approximately $830.3 million in net proceeds for growth initiatives and debt reduction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-01
Item 8.01
The filing discloses material progress on a previously announced Business Combination between Valaris and Transocean, specifically the satisfaction of CFIUS approval on June 29, 2026, and ongoing HSR Act review by the DOJ. The transaction involves Transocean acquiring all outstanding Valaris shares at a fixed exchange ratio (15.235 Transocean shares per Valaris share), representing a material change of control event that would materially affect a reasonable investor's assessment of Valaris.
View raw filing on EDGAR →